Wearable Biosensors are Changing the Future of Clinical Trials
Clinical trialists have moved to an older trial model requiring less patient mobility and preferably centered at home, but now with innovative next-gen remote biosensing…
Partnership with Greenleaf Enhances Strategic Regulatory Affairs Capabilities
"This partnership strengthens our global Regulatory Affairs offering and allows us to expand our strategic capabilities to support our Sponsors’ programs.” - Jon Isaacsohn, MD,…
Chronic Kidney Disease & Its Impact on Clinical Development – Part 1
Recently, medical and operational experts from our nephrology team presented a webinar on Chronic Kidney Disease (CKD). Over the next several weeks, we will build…
Medpace Clinical Pharmacology Unit working with HiFiBIO Therapeutics on a SARS-CoV-2 ID-neutralizing antibody for the treatment and prevention of COV19
In a recent news release, HiFiBiO Therapeutics announced the successful completion of the first cohort of the Phase I study (NCT04590430) of HFB30132 which was…
New White Paper: The Intersection of Rare Diseases and Advanced Therapies and What it Means for Clinical Development
Read the press release for the latest whitepaper on advanced therapies and rare diseases published by Xtalks and Medpace.
Spotlight on Rare Disease Clinical Development
There is a lot of uncertainty in the world right now, but one thing for certain is that rare disease and orphan indication clinical research…
Webinar: How A Deeper Understanding of Chronic Kidney Disease Is Impacting Clinical Development
Medpace’s experts will be discussing important topics from both a medical and operational perspective.
The Evolving Landscape of Therapeutic and Diagnostic Radiopharmaceuticals
In a new article, experts from Medpace’s radiation oncology, imaging, regulatory, and operational teams discuss the growing space of radiopharmaceutical development.
Rare Disease Spotlight: Acromegaly
Learn more about acromegaly and our capabilities for clinical trials.
Operationalizing Complex Innovative Trial Design (FDA’s New Approach)
One of the FDA’s recent initiatives centers on operationalizing complex innovative trial design. Learn more about the types of trials the FDA consider innovative and the…